17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 13 (HSD17B13) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2025333737-A1 · Oct 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Li Alexander patents
Li Alexander is listed as an inventor on 22 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Li Alexander |
| Total patents | 22 |
| First publication | Aug 2, 2018 |
| Latest publication | Oct 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof
US-12359201-B2 · Jul 15, 2025 · US
Methods Of Treating Skin Cancer With Histidine Ammonia-Lyase (HAL) Agonists
US-2025170226-A1 · May 29, 2025 · US
Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonists
US-12186378-B2 · Jan 7, 2025 · US
Hsd17b13 variants and uses thereof
US-2024141305-A1 · May 2, 2024 · US
HSD17B13 variants and uses thereof
US-11845963-B2 · Dec 19, 2023 · US
HSD17B13 variants and uses thereof
US-11753628-B2 · Sep 12, 2023 · US
Treatment Of Inflammatory Diseases With RAS Protein Activator Like 3 (RASAL3) Inhibitors
US-2023074721-A1 · Mar 9, 2023 · US
Treatment of Varicose Veins With Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Agonists
US-2023041060-A1 · Feb 9, 2023 · US
Hsd17b13 variants and uses thereof
US-2023031669-A1 · Feb 2, 2023 · US
Recent patents
Latest publications not already listed above.
Treatment of Hypertension With Solute Carrier Family 9 Isoform A3 Regulatory Factor 2 (SLC9A3R2) Inhibitors
US-2023027007-A1 · Jan 26, 2023 · US
Methods Of Treating A Metabolic Disorder With Mitogen-Activated Protein Kinase Kinase Kinase 15 (MAP3K15) Inhibitors
US-2023025878-A1 · Jan 26, 2023 · US
Methods Of Treating Asthma With Solute Carrier Family 27 Member 3 (SLC27A3) Inhibitors
US-2023023182-A1 · Jan 26, 2023 · US
Methods Of Treating Skin Cancer With Histidine Ammonia-Lyase (HAL) Agonists
US-2023016750-A1 · Jan 19, 2023 · US
HSD17B13 variants and uses thereof
US-11485958-B2 · Nov 1, 2022 · US
HSD17B13 Variants And Uses Thereof
US-2022267743-A1 · Aug 25, 2022 · US
17ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof
US-2021380985-A1 · Dec 9, 2021 · US
17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof
US-11180757-B1 · Nov 23, 2021 · US
Hsd17b13 variants and uses thereof
US-2020354693-A1 · Nov 12, 2020 · US
HSD17B13 variants and uses thereof
US-10787647-B2 · Sep 29, 2020 · US
HSD17B13 Variants And Uses Thereof
US-2018216104-A1 · Aug 2, 2018 · US
Hsd17b13 variants and uses thereof
US-2018216084-A1 · Aug 2, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 22 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/14 | 18 |
| C12N15/113 | 17 |
| A61K31/713 | 17 |
| C12Q2600/156 | 17 |
| C12Q1/6883 | 15 |